New Vernon Capital Holdings II’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-243,734
Closed -$16.4M 84
2025
Q1
$16.4M Buy
243,734
+230,650
+1,763% +$3.55M 0.37% 26
2024
Q4
$195K Hold
13,084
0.13% 51
2024
Q3
$250K Buy
13,084
+7,686
+142% +$159K 0.13% 55
2024
Q2
$112K Buy
+5,398
New +$107K 0.06% 56
2024
Q1
Sell
-29,773
Closed -$429K 90
2023
Q4
$429K Buy
+29,773
New +$405K 0.23% 50
2023
Q2
Sell
-6,143
Closed -$144K 86
2023
Q1
$144K Buy
6,143
+63
+1% +$1.69K 0.11% 72
2022
Q4
$170K Buy
6,080
+1,563
+35% +$40K 0.14% 65
2022
Q3
$106K Sell
4,517
-5,171
-53% -$156K 0.11% 54
2022
Q2
$327K Buy
+9,688
New +$339K 0.26% 27

Other funds holding OGN

New Vernon Capital Holdings II's OGN Position: Q2 2025 in Review

New Vernon Capital Holdings II sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 243,734 shares — an estimated $16.4M sold.

New Vernon Capital Holdings II first reported a position in OGN in Q2 2022 and held it in 9 quarters. The position peaked at $16.4M in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • New Vernon Capital Holdings II reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 243,734 Organon & Co shares in Q2 2025, an estimated $16.4M.
  • New Vernon Capital Holdings II first reported a position in Organon & Co in Q2 2022 and held it in 9 quarters.
  • New Vernon Capital Holdings II's Organon & Co position peaked at $16.4M in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on New Vernon Capital Holdings II's 13F filing for Q2 2025, filed 14 Aug 2025.